A	O
4	O
.	O
5	O
mm	O
fibreoptic	O
bronchoscope	O
(	O
UE	O
Medical	O
Company	O
Ltd	O
,	O
Zhejiang	O
,	O
China	O
)	O
loaded	O
with	O
a	O
lubricated	O
reinforced	O
Parker	O
Flex	O
-	O
Tip	O
Â®	O
tracheal	O
tube	O
(	O
Well	O
Lead	O
Medical	O
Company	O
Ltd	O
.	O
,	O
Guangzhou	O
,	O
China	O
)	O
was	O
inserted	O
until	O
the	O
carina	O
was	O
visualised	O
,	O
and	O
the	O
tube	O
was	O
advanced	O
over	O
the	O
bronchoscope	O
into	O
the	O
trachea	O
.	O

During	O
attempts	O
at	O
tracheal	O
intubation	O
,	O
HFNO	O
was	O
maintained	O
for	O
the	O
HFNO	O
group	O
,	O
whereas	O
no	O
oxygen	O
was	O
administered	O
for	O
the	O
SMO	O
group	O
.	O

After	O
removal	O
of	O
the	O
bronchoscope	O
,	O
successful	O
intubation	O
was	O
confirmed	O
by	O
capnography	O
.	O

If	O
Spo2	O
<	O
90	O
%	O
occurred	O
during	O
intubation	O
,	O
bronchoscopy	O
was	O
terminated	O
and	O
face	O
-	O
mask	O
ventilation	O
was	O
initiated	O
to	O
correct	O
desaturation	O
.	O

The	O
primary	O
endpoint	O
was	O
the	O
total	B-PrimaryOutcome
time	I-PrimaryOutcome
of	I-PrimaryOutcome
intubation	I-PrimaryOutcome
,	O
defined	O
as	O
the	B-OutcomeDefinition
sum	I-OutcomeDefinition
of	I-OutcomeDefinition
the	I-OutcomeDefinition
time	I-OutcomeDefinition
spent	I-OutcomeDefinition
from	I-OutcomeDefinition
the	I-OutcomeDefinition
beginning	I-OutcomeDefinition
of	I-OutcomeDefinition
bronchoscopy	I-OutcomeDefinition
until	I-OutcomeDefinition
proper	I-OutcomeDefinition
tracheal	I-OutcomeDefinition
tube	I-OutcomeDefinition
placement	I-OutcomeDefinition
was	I-OutcomeDefinition
confirmed	I-OutcomeDefinition
.	O

The	O
secondary	O
endpoints	O
included	O
the	O
lowest	B-SecondaryOutcome
Spo2	I-SecondaryOutcome
during	I-SecondaryOutcome
intubation	I-SecondaryOutcome
,	O
incidence	B-SecondaryOutcome
of	I-SecondaryOutcome
mask	I-SecondaryOutcome
ventilation	I-SecondaryOutcome
for	I-SecondaryOutcome
Spo2	I-SecondaryOutcome
<	I-SecondaryOutcome
90	I-SecondaryOutcome
%	I-SecondaryOutcome
,	O
Pao2	B-SecondaryOutcome
/	I-SecondaryOutcome
Fio2	I-SecondaryOutcome
before	I-SecondaryOutcome
intubation	I-SecondaryOutcome
,	O
incidence	B-SecondaryOutcome
of	I-SecondaryOutcome
Spo2	I-SecondaryOutcome
<	I-SecondaryOutcome
80	I-SecondaryOutcome
%	I-SecondaryOutcome
during	I-SecondaryOutcome
intubation	I-SecondaryOutcome
,	O
incidence	B-SecondaryOutcome
of	I-SecondaryOutcome
minimum	I-SecondaryOutcome
Spo2	I-SecondaryOutcome
>	I-SecondaryOutcome
95	I-SecondaryOutcome
%	I-SecondaryOutcome
during	I-SecondaryOutcome
intubation	I-SecondaryOutcome
,	O
and	O
7	B-TimeFrame
day	I-TimeFrame
mortality	B-SecondaryOutcome
.	O

